Microrna-21 antagonists and its target PDCD4 for use in the treatment of a glioma
The present invention embraces microRNA-21 antagonists and activators of Programmed Cell Death 4 for use in decreasing glial tumor cell proliferation and treating glioma.
GAUR ARTI [US]; ISRAEL MARK A [US]
Type of Offer:
« More Biotech Patents